Quantcast

Latest HAIFA Stories

2014-08-21 04:20:39

HAIFA, Israel, Aug. 21, 2014 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (hereinafter "the Company," "ORL" or "BAZAN"), Israel's largest integrated refining and petrochemical group, announced its financial results for the second quarter and first half 2014. The Company will be hosting its earnings call today, August 21, 2014. The conference call will take place at 13:30 UK (08:30 ET, 15:30 Israel time). On the call, management will review and discuss the financial results and will be...

2014-07-23 23:14:57

"Operation Safe Haven" Moving Hundreds Out of Harm's Way as Bombs Fall from Gaza New York, NY (PRWEB) July 23, 2014 The Israel Tennis Centers Foundation announced an emergency relief effort in response to the immediate and growing crisis affecting the children and families of the Israel Tennis Centers in southern Israel, the region hardest hit by the rockets that continue to rain down. With Hamas firing thousands of rockets into Israel in the past two weeks, Israel's...

2014-07-16 12:28:14

NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Alzheimer's disease affects approximately 5.2 million people in the United States alone, and it is the nation's sixth leading cause of death. A cure for this insidious killer has so far proven elusive, but that could soon change as a result of a breakthrough at the Technion-Israel Institute of Technology that sheds light on a key mechanism in the accumulation of protein plaques in the tissue of Alzheimer's disease patients. The...

2014-05-21 04:20:33

HAIFA, Israel, May 21, 2014 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (hereinafter "the Group," "ORL"), Israel's largest integrated refining and petrochemical group, announced its financial results for the first quarter 2014. The Company will be hosting its earnings call today, May 21, 2014. The conference call will take place at 13:30 UK (08:30 ET, 15:30 Israel time). On the call, management will review and discuss the first quarter 2014 financial results and will be available to...

2014-05-19 08:22:30

HAIFA, Israel, May 19, 2014 /PRNewswire/ -- Conference Call Scheduled for May 21, 2014 at 13:30 UK Time, 08:30 ET Oil Refineries Ltd. (TASE: ORL.TA) (the "Company"), Israel's largest integrated refining and petrochemical group, announced today that it will be hosting its earnings call for the First quarter 2014 on Wednesday, May 21, 2014. The conference call will take place at 13:30 UK (08:30 ET, 13:30 Israel time). On the call, management will review and...

2014-04-23 16:26:38

LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Micronutrient Market by Type (Zinc, Manganese, Boron, Copper, Molybdenum, Iron), Form (Chelated & Non Chelated), Application Mode (Soil, Foliar, Fertigation), Crop Type & Geography - Global Trends and Forecast to...

2014-04-03 12:29:26

HAIFA, Israel, April 3, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that new, pre-clinical data demonstrating the anti-tumor effects of NovoTTF(TM) Therapy will be presented at the 2014 American Association for Cancer Research (AACR) in San Diego (April 5-9, 2014). The new study results show that ovarian cancer cells treated with Tumor Treating Fields (TTFields) exhibit abnormal chromosomal separation during cell division, reducing the viability of...

2014-03-24 08:22:14

HAIFA, Israel, March 24, 2014 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (hereinafter "the Group," "ORL"), Israel's largest integrated refining and petrochemical group, announced its financial results for the fourth quarter and full year 2013. The Company will be hosting its earnings call for Monday, March 24, 2014 at 13:30 UK (08:30 ET, 15:30 Israel time). Results are reported in US Dollars and under International Financial Reporting Standards (IFRS). FOURTH...

2014-01-24 08:24:33

HAIFA, Israel, Jan. 24, 2014 /PRNewswire/ -- Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma. NovoTTF Therapy is an anti-mitotic treatment delivered continuously with a wearable, home-use medical device. "The EF-20 study builds on extensive preclinical research demonstrating the...

2014-01-06 08:27:57

HAIFA, Israel, Jan. 6, 2014 /PRNewswire/ -- Novocure(TM) announced today that the first evidence of activity of NovoTTF Therapy in pancreatic cancer tumor models was published online (December 16(th), 2013) in the prestigious peer reviewed journal Pancreatology. The published study showed that application of NovoTTF Therapy to pancreatic cancer cells in vitro leads to a significant decrease in cell count and reduced ability to form clones. Further analysis demonstrated a significant...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related